Position in ALNY
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$471,489
+$135,475 QoQ
Shares Held
1,425
+68.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEPHENS INC /AR/ holds $6,968,085 across 12 Biotechnology names. ALNY ranks #6 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
26,761 | $2,009,483 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,951 | $1,317,739 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
887 | $685,331 | |
| 4 | TECH |
BIO-TECHNE Corp
|
12,422 | $649,173 | |
| 5 | EXEL |
Exelixis, Inc.
|
13,634 | $584,762 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,425 | $471,489 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
1,625 | $324,431 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,557 | $294,518 |
All Filings in ALNY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $471,489 | 1,425 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $336,014 | 845 | Shares | Defined | 2026-02-05 | |
| 2025-09-30 | $318,744 | 699 | Shares | Defined | 2025-10-27 | |
| 2025-06-30 | $207,067 | 635 | Shares | Defined | 2025-07-29 | |
| No filing history on record for this holder in this stock. | ||||||